Gram Research analysis of a 2026 study in Virulence found that baker’s yeast with the CYB2 gene removed slowed the growth of several harmful bacteria, including drug-resistant strains. In mice, this modified yeast improved survival and reduced bacterial counts in the bladder and intestines. Lactic acid appears to be the main reason, but human safety and benefits remain untested.
Gram Research analysis of a study published in Virulence found that a modified baker’s yeast, with a gene called CYB2 removed, slowed the growth of many harmful bacteria, including some that resist antibiotics. Researchers screened 1,733 yeast strains before selecting this one. In mice with urinary tract infections or intestinal inflammation, the modified yeast was linked to better survival and fewer harmful bacteria in the bladder and gut. The yeast appears to work by producing lactic acid, which makes its surroundings more acidic and less hospitable to bacteria. These results come from lab and animal studies only, so it is too early to know whether this yeast would help people. Still, the work points to a possible new way to design probiotics.
Key Statistics
A 2026 study published in Virulence screened 1,733 baker’s yeast strains and identified one with the CYB2 gene removed as having potent antibacterial activity against harmful bacteria.
In a 2026 Virulence study, mice treated with CYB2-knockout yeast showed improved survival and fewer bacteria in the bladder, ileum, colon, and cecum, according to research reviewed by Gram.
The 2026 Virulence study found that removing the CYB2 gene caused the yeast to produce more lactic acid, which lowered the acidity of its surroundings and appeared to be the main driver of its antibacterial effect.
The Quick Take
- What they studied: Can a specially modified yeast fight harmful bacteria, and how does it do so?
- Who participated: The researchers screened 1,733 yeast strains from a collection of gene-altered baker’s yeast. They then tested the best candidate in lab dishes and in mice. No human volunteers were part of this study.
- Key finding: A yeast strain with the CYB2 gene removed slowed the growth of several harmful bacteria, including drug-resistant types. Mice given this yeast had better survival and fewer bacteria in the bladder and intestines. The researchers found that lactic acid, which the yeast produced in larger amounts, appears to be the main reason for these effects.
- What it means for you: This is early laboratory and animal research, so it does not show that this yeast is safe or helpful for people. Do not replace medical treatment for an infection with any probiotic. If you are considering a probiotic, talk with your doctor first, especially if you have a weakened immune system.
The Research Details
The researchers began by testing a random selection of 1,733 strains from a large library of baker’s yeast in which individual genes had been switched off one at a time. This library lets scientists see what happens when a specific gene is missing. They grew each strain alongside harmful bacteria and looked for strains that blocked bacterial growth. One strain, with the CYB2 gene removed, stood out.
Next, the team tested this strain in more detail. They checked whether it could stop bacteria from sticking together and forming protective films, which make infections harder to treat. They also checked whether the yeast was harmless to red blood cells and whether it could survive the acid in the stomach and the bile salts in the intestines. In addition, they studied how the yeast affected bacterial cell walls and membranes.
Finally, the researchers tested the yeast in mice with urinary tract infections and with intestinal infections. They measured survival and bacterial counts in several organs. To find the cause of the effect, they compared the yeast’s chemical byproducts with pure lactic acid, adjusted acidity levels in some experiments, and added lactic acid back into a control solution to see whether it reproduced the effect.
Screening a large set of yeast strains helped the researchers find a candidate that a targeted search might have missed. Testing the strain in several ways, from dishes to living animals, shows whether the effect holds up across different settings. The control experiments, such as adjusting acidity and adding lactic acid directly, helped the team test whether lactic acid was truly responsible rather than just correlated with the effect.
The study used several complementary methods, and the authors ran direct tests of their proposed mechanism, which strengthens confidence in their explanation. Still, the work was done in yeast cells, bacteria in dishes, and mice. Results in these settings often do not carry over to people. The abstract does not report the number of mice used, so it is harder to judge how much weight the animal results can bear. The paper has not yet been widely replicated by independent teams.
What the Results Show
The modified yeast strain was effective at slowing the growth of several harmful bacteria, including strains that resist multiple antibiotics. It also reduced the ability of bacteria to form biofilms, which are slimy, protective layers that make infections harder to clear. The researchers found that the yeast reduced bacteria’s ability to stick to surfaces and to produce their protective coating.
The yeast also appeared to work well under the harsh conditions of the digestive tract. It tolerated acidic conditions and high levels of bile salts, and it did not damage red blood cells in tests. It clumped together with itself and with bacteria, which may help it trap harmful microbes.
In mice, the modified yeast was linked to better survival and lower bacterial counts in the bladder, small intestine (ileum), large intestine (colon), and cecum. These results suggest the yeast can reduce infection in living animals, not just in lab dishes.
The researchers traced the effect to lactic acid. When the CYB2 gene was removed, the yeast produced more lactic acid, which made its surroundings more acidic. When the acidity was neutralized, the protective effect weakened. Adding lactic acid directly reproduced the effect, which supports the idea that lactic acid is the key active substance.
The yeast’s ability to stick to both itself and to bacteria may matter as much as its acid production, because it could physically help clear harmful microbes from the body. Its tolerance of stomach acid and bile is important, since a probiotic must survive the digestive tract to be useful. The lack of red blood cell damage is an early safety signal, although it is far from a full safety evaluation.
Lactic acid is already known to be produced by many helpful bacteria and is one reason some fermented foods resist spoilage and harmful microbes. This study adds to that knowledge by showing that a yeast can be engineered to produce more of it and that the extra acid appears to fight infection. Earlier probiotic research often described benefits without identifying the mechanism. This work attempts to pin down the specific chemical responsible, which is a step toward designing better probiotics.
The most important limitation is that the work was done in yeast, bacteria in dishes, and mice. Human digestive systems, immune responses, and infections are more complex, and results in animals do not always translate to people. The abstract does not report sample sizes for the mouse experiments, which makes it harder to judge how strong the animal findings are. The study does not describe long-term safety, such as what happens after repeated doses or in people with weakened immune systems. Finally, the researchers have not yet shown that the modified yeast works better than existing treatments.
The Bottom Line
Based on current evidence, this research is promising but early. Lab and animal results point toward a possible new probiotic approach, with moderate confidence in the lab findings and lower confidence in how the results would apply to people. No recommendation to use this yeast as a treatment can be made yet. Standard care for bacterial infections, including antibiotics when prescribed, remains the reliable option today.
Researchers who study probiotics, infections, and drug-resistant bacteria should pay close attention. People with urinary tract infections or digestive infections may find the work encouraging, but it does not change their treatment options yet. People with weakened immune systems should be especially careful about any probiotic, and should not use this yeast without medical guidance. Readers looking for a quick fix for infections should know this research is far from clinical use.
Moving from animal research to human use usually takes many years. The next steps would likely include safety studies, dose-finding studies, and small human trials before larger testing. Realistically, any benefit for patients would be years away and is not guaranteed.
Frequently Asked Questions
Can a modified yeast help fight urinary tract infections?
Lab and animal research suggests it may. In a 2026 study in Virulence, mice with urinary tract infections given a modified baker’s yeast had better survival and fewer bacteria in the bladder. Human testing has not been done, so it is not a treatment yet.
What is CYB2-knockout yeast?
CYB2-knockout yeast is baker’s yeast in which the CYB2 gene has been switched off. Removing this gene caused the yeast to produce more lactic acid, which researchers found slowed the growth of several harmful bacteria in lab and animal tests.
How does this yeast kill harmful bacteria?
It does not appear to kill bacteria directly. Instead, the yeast produces extra lactic acid, which makes its surroundings more acidic. Research reviewed by Gram found that neutralizing the acidity weakened the effect, and adding lactic acid alone reproduced it.
Is a probiotic yeast a replacement for antibiotics?
No. The research suggests probiotics may be a future alternative, but this yeast has only been tested in lab dishes and mice. Antibiotics remain the standard treatment for many bacterial infections, and you should follow your doctor’s guidance.
Want to Apply This Research?
- Track your daily fiber intake, fermented food servings, and any digestive symptoms such as bloating or stool changes on a 1 to 5 scale. Note any probiotic supplements you take, including the brand and dose. Record any bladder or urinary symptoms and whether you contacted a doctor, so you have a clear picture to share at appointments.
- Encourage regular intake of foods that naturally contain lactic-acid-producing bacteria, such as yogurt with live cultures, kefir, sauerkraut, and kimchi, while keeping in mind that this research did not test these foods. Set a reminder to drink enough water, which supports urinary health. If you have recurrent urinary or digestive symptoms, use the app to log them and schedule a conversation with a healthcare provider.
- Review your symptom and food logs monthly to spot patterns over time. Keep an eye on new research in this area, and update your app notes when findings from human trials are published. If you ever start a probiotic, log it along with symptoms for at least 8 to 12 weeks so you can judge whether it made a difference. Share the long-term summary with your doctor.
This article summarizes laboratory and animal research and is for general information only. The yeast described has not been tested in human clinical trials and is not an approved treatment for any infection. Do not use this yeast or any probiotic to treat an infection without consulting a qualified healthcare provider. If you have symptoms of a urinary or digestive infection, seek medical care promptly.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.